Linfologia & Microchirurgia


  • Benzopyrones (b.): Include coumarin and derivatives (alpha-b.) and bioflavonoids and derivatives (gamma-b. – diosmin, rutin, hesperidin, quercetin, etc.).

The activity of alpha-b. consists of:

    • Increase in capillary tone
    • Decreased capillary permeability to proteins
    • Increase in macrophage numbers
    • Activation of macrophage proteolytic activity
    • Stimulation of the propulsive activity of the lymphangion
    • Inhibition of the synthesis of prostaglandins and leukotrienes


    Therefore, the effects are:

    • Interstitial fluid reabsorption
    • Gradual regression of fibrosis, favored by macrophage proteolysis
    • Reduction of chronic inflammatory stimulation, with consequent lower incidence of acute episodes and less tendency of the edema towards fibrosis.


    Natural cumarins, administered at doses of 8 mg / day for 60 days, have shown therapeutic efficacy with improvement in subjective symptoms, functional recovery of the lymphedematous limb, reduction of edema consistency, enhancement of excess volume reduction obtained after sequential physical and / or microsurgical-liposuction treatment, without causing any toxic effect for the liver.

The actions of the gamma-b. include:

  • Reduction of permeability of the endothelium to protein macromolecules
  • Reduction of capillary filtration
  • Increase in venular tone

Therefore, the effects are:

  • Stabilizing action on the interstitial connective tissue and on the capillary wall.
  • Inhibition of the production of prostaglandins and leukotrienes.
  • Antibiotics:  are used in the acute phase (therapy for Beta-hemolytic streptococcus), for the treatment of dermato-lymphangio-adenitis (DLA), and for preventive purposes for the prophylaxis of episodes of acute lymphangitis (long-lasting penicillin).
  • Antifungals: for the treatment of fungal infections of the extremities (fluconazole, etc.).
  • Diethylcarbamazine: for the elimination of microfilaria from the bloodstream in patients with parasitic-based lymphedema.
  • Diuretics: usually at low dosage and for short periods of treatment, especially in lymphedema associated with phlebedema or other diseases such as cardiopathies, kidney disease, ascites, pathologies of chyliferous vessels, etc.
  • Diet: in obese patients, the reduction of caloric intake, in association with a suitable program of physical activity, has its own specific effectiveness in reducing the volume of the lymphedematous limb. The validity of a limited intake of fluids has not been demonstrated. In syndromes with chylous reflux, a diet low in lipids and with the exclusive intake of medium chain triglycerides (medium chain triglycerides – MCT), which are absorbed through the portal circuit, and therefore do not overload the system of chyliferous vessels, is extremely effective, even in the pediatric age.

Therefore, there is a wide range of pharmacological therapeutic principles. The choice is based on the etiopathogenetic and pathophysiological aspects of each type of lymphedema.

subscribe to
the newsletter

The user’s personal data are used by Lymphaticsurgery, which is the data controller, in compliance with the principles of protection of personal data established by the GDPR 2016/679 Regulation.

1) We inform you that the data will be processed with the support of the following means:
a) Paper (registration forms, order forms, etc.)
b) IT (management software, accounting, etc.)
c) Telematics
with the following purposes:
– provision of the services requested by the Customer or available on portals managed by (personnel selection, newsletters, information material, free material) as well as the conclusion of the contract of which the interested party is a party;
– administrative and accounting purposes related to service contracts;
Any refusal to allow the processing of data will make it impossible to use the service requested by the user.

2) The provision of data is mandatory for all that is required by legal and contractual obligations and therefore any refusal to provide them in whole or in part may result in the impossibility of providing the requested services.
The company processes the user’s optional data on the basis of consent, i.e. through the explicit approval of this privacy policy and in relation to the methods and purposes described below.

3) Without prejudice to communications made in fulfillment of legal and contractual obligations, all data collected and processed may be communicated exclusively for the purposes specified above to the following categories of interested parties:
– Commercial consultants;
– Accounting and administrative;
– Suppliers.
– Customers (patients)

4) The data required for contractual and accounting purposes are kept for the time necessary to carry out the commercial and accounting relationship. The data of those who do not purchase or use products / services, despite having had a previous contact with company representatives, will be immediately deleted or treated anonymously, where their conservation is not otherwise justified, unless it has been validly acquired. the informed consent of the interested parties relating to a subsequent commercial promotion or market research activity. Data retention will comply with the laws in force on the matter.

5) Pursuant to European Regulation 679/2016 (GDPR) and national legislation, the interested party may, according to the methods and within the limits established by current legislation, exercise the following rights:
– request confirmation of the existence of personal data concerning him (right of access);
– know its origin;
– receive intelligible communication;
– have information about the logic, methods and purposes of the processing;
– request the updating, rectification, integration, cancellation, transformation into anonymous form, blocking of data processed in violation of the law, including those no longer necessary for the pursuit of the purposes for which they were collected;
– in cases of consent-based processing, receive their data provided to the owner, in a structured and readable form by a data processor and in a format commonly used by an electronic device;
– the right to lodge a complaint with the supervisory authority.
Requests should be addressed to the Data Controller.
6) The data controller of your personal data is Lymphaticsurgery – Via Assarotti 46 / 1- 16132 Genova (GE), Italy E-mail: info@campisiandpartners.com, genovamedicalcentersrl@pec.it Tel./Fax: +39 010 83 93 755

This privacy policy may undergo changes over time – also related to the possible entry into force of new sector regulations, the updating or provision of new services or technological innovations – for which the user / visitor is invited to consult periodically at the privacy button at the bottom of www.lymphaticsurgery.it. The information is printable and can be saved.